Veeda Clinical Research IPO Date, Price, GMP, Details

Veeda Clinical Research IPO

The Veeda Clinical Research IPO is a book-built issue, which consists of a fresh issue of up to ₹185 crore and an offer for sale (OFS) of up to 13,008,128 equity shares. The DRHP was filed by the company on January 31, 2025, and received approval by July 3, 2025. The shares are expected to be listed on the BSE and NSE platforms.

While the specific price band and the official open and close dates will be announced by the company later, this issue is managed by experienced lead managers, including Axis Capital Ltd., CLSA India Private Ltd., IIFL Capital Services Ltd., and SBI Capital Markets Ltd., with Link Intime India Private Ltd. serving as the registrar to the issue.